Cathy Friedman - Net Worth and Insider Trading

Cathy Friedman Net Worth

The estimated net worth of Cathy Friedman is at least $6 Million dollars as of 2024-11-07. Cathy Friedman is the Director of Lyell Immunopharma Inc and owns about 3,883,490 shares of Lyell Immunopharma Inc (LYEL) stock worth over $6 Million. Details can be seen in Cathy Friedman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cathy Friedman has not made any transactions after 2021-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Cathy Friedman

Cathy Friedman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cathy Friedman owns 10 companies in total, including Radius Health Inc (RDUS) , Altaba Inc (AABA) , and Innoviva Inc (INVA) among others .

Click here to see the complete history of Cathy Friedman’s form 4 insider trades.

Insider Ownership Summary of Cathy Friedman

Ticker	Comapny	Transaction Date	Type of Owner
RDUS	Radius Health Inc	2022-08-15	director
AABA	Altaba Inc	2017-06-13	director
INVA	Innoviva Inc	2014-12-22	director
		2016-07-05	director
		2015-05-06	director
		2013-03-08	director
		2021-06-17	director
		2021-06-21	director
		2021-03-17	director
		2021-03-17	director

Cathy Friedman Latest Holdings Summary

Cathy Friedman currently owns a total of 1 stock. Cathy Friedman owns 3,883,490 shares of Lyell Immunopharma Inc (LYEL) as of June 21, 2021, with a value of $6 Million.

Latest Holdings of Cathy Friedman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
LYEL	Lyell Immunopharma Inc	2021-06-21	3,883,490	1.48	5,728,148

Holding Weightings of Cathy Friedman

Cathy Friedman Form 4 Trading Tracker

According to the SEC Form 4 filings, Cathy Friedman has made a total of 1 transactions in Lyell Immunopharma Inc (LYEL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lyell Immunopharma Inc is the acquisition of 17,648 shares on June 21, 2021, which cost Cathy Friedman around $300,016.

Insider Trading History of Cathy Friedman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cathy Friedman Trading Performance

GuruFocus tracks the stock performance after each of Cathy Friedman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cathy Friedman is -33.97%. GuruFocus also compares Cathy Friedman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cathy Friedman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cathy Friedman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cathy Friedman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-5.76
Relative Return to S&P 500(%)	-8.93

Cathy Friedman Ownership Network

Ownership Network List of Cathy Friedman

No Data

Ownership Network Relation of Cathy Friedman

Cathy Friedman Owned Company Details

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Cathy Friedman is the director of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Altaba Inc do?

Who are the key executives at Altaba Inc?

Cathy Friedman is the director of Altaba Inc. Other key executives at Altaba Inc include Chief Financial Officer Alexi Wellman , 10 percent owner Christopher Hohn , and Chief Financial Officer Kenneth A Goldman .

Altaba Inc (AABA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Altaba Inc (AABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Altaba Inc (AABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Altaba Inc (AABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altaba Inc Insider Transactions

No Available Data

What does Innoviva Inc do?

Who are the key executives at Innoviva Inc?

Cathy Friedman is the director of Innoviva Inc. Other key executives at Innoviva Inc include Chief Accounting Officer Marianne Zhen , Chief Financial Officer Stephen Basso , and Chief Medical Officer Margaret Koziel .

Innoviva Inc (INVA) Insider Trades Summary

Over the past 18 months, Cathy Friedman made no insider transaction in Innoviva Inc (INVA). Other recent insider transactions involving Innoviva Inc (INVA) include a net purchase of 723,000 shares made by Alexander J Denner , and a net sale of 10,994 shares made by Marianne Zhen .

In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,994 shares of Innoviva Inc (INVA) were sold and 723,000 shares were bought by its insiders, resulting in a net purchase of 712,006 shares.

Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innoviva Inc Insider Transactions

No Available Data

What does XenoPort Inc do?

Who are the key executives at XenoPort Inc?

Cathy Friedman is the director of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .

XenoPort Inc (XNPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

XenoPort Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Cathy Friedman is the director of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

What does SuRo Capital Corp do?

Who are the key executives at SuRo Capital Corp?

Cathy Friedman is the director of SuRo Capital Corp. Other key executives at SuRo Capital Corp include director & CEO and President Mark D Klein , See Remarks Allison Green , and 10 percent owner Robert S. Birch .

SuRo Capital Corp (SSSS) Insider Trades Summary

Over the past 18 months, Cathy Friedman made no insider transaction in SuRo Capital Corp (SSSS). Other recent insider transactions involving SuRo Capital Corp (SSSS) include a net purchase of 126,000 shares made by Mark D Klein ,

In summary, during the past 3 months, insiders sold 0 shares of SuRo Capital Corp (SSSS) in total and bought 12,000 shares, with a net purchase of 12,000 shares. During the past 18 months, 0 shares of SuRo Capital Corp (SSSS) were sold and 126,000 shares were bought by its insiders, resulting in a net purchase of 126,000 shares.

SuRo Capital Corp (SSSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

SuRo Capital Corp Insider Transactions

No Available Data

What does Seer Inc do?

Who are the key executives at Seer Inc?

Cathy Friedman is the director of Seer Inc. Other key executives at Seer Inc include director & 10 percent owner & CEO and Chair of the Board Omid Farokhzad , Chief Financial Officer David R. Horn , and General Counsel and Secretary Elona Esq. Kogan .

Seer Inc (SEER) Insider Trades Summary

Over the past 18 months, Cathy Friedman made no insider transaction in Seer Inc (SEER). Other recent insider transactions involving Seer Inc (SEER) include a net sale of 20,866 shares made by Elona Esq. Kogan , a net sale of 16,292 shares made by David R. Horn , and a net sale of 12,857 shares made by Omid Farokhzad .

In summary, during the past 3 months, insiders sold 0 shares of Seer Inc (SEER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,592 shares of Seer Inc (SEER) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 63,592 shares.

Seer Inc (SEER)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seer Inc Insider Transactions

No Available Data

What does Lyell Immunopharma Inc do?

Who are the key executives at Lyell Immunopharma Inc?

Cathy Friedman is the director of Lyell Immunopharma Inc. Other key executives at Lyell Immunopharma Inc include director & Executive Chairman Richard Klausner , Chief Business Officer Matthew Lang , and Chief Legal Officer Rahsaan Thompson .

Lyell Immunopharma Inc (LYEL) Insider Trades Summary

Over the past 18 months, Cathy Friedman made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net sale of 58,020 shares made by Richard Klausner ,

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,020 shares of Lyell Immunopharma Inc (LYEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,020 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lyell Immunopharma Inc Insider Transactions

No Available Data

What does Revolution Healthcare Acquisition Corp do?

Who are the key executives at Revolution Healthcare Acquisition Corp?

Cathy Friedman is the director of Revolution Healthcare Acquisition Corp. Other key executives at Revolution Healthcare Acquisition Corp include Chief Operating Officer Paul Fielding , Chief Operating Officer Evan Sotiriou , and Chief Financial Officer Mark Mcdonnell .

Revolution Healthcare Acquisition Corp (REVHU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Healthcare Acquisition Corp (REVHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Healthcare Acquisition Corp (REVHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Healthcare Acquisition Corp (REVHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Healthcare Acquisition Corp Insider Transactions

No Available Data

What does Revolution Healthcare Acquisition Corp do?

Who are the key executives at Revolution Healthcare Acquisition Corp?

Revolution Healthcare Acquisition Corp (REVH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Healthcare Acquisition Corp (REVH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Healthcare Acquisition Corp (REVH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Healthcare Acquisition Corp (REVH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Healthcare Acquisition Corp Insider Transactions

No Available Data

Cathy Friedman Mailing Address

Above is the net worth, insider trading, and ownership report for Cathy Friedman. You might contact Cathy Friedman via mailing address: C/o Innoviva, Inc., 2000 Sierra Point Parkway, Suite 500, Brisbane Ca 94005.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.